NDC codes

416497 NDC codes with hospital pricing data in the network.

• NDC 00270-5164-13 — Multihance contrast injection for imagingAI (405 hospitals, 24,800–27,032 samples)
• NDC 68382-0132-01 — TAMSULOSIN 0.4 MG CAPSULEAI (303 hospitals, 26,348–27,023 samples)
• NDC 67877-0223-05 — gabapentin 300 mg capsuleAI (260 hospitals, 26,348–27,023 samples)
• NDC 70860-0600-02 — Midazolam 1 mg/mL injectionAI (254 hospitals, 23,367–27,012 samples)
• NDC 00338-1138-03 — Amino acid and dextrose intravenous solutionAI (251 hospitals, 26,744–27,005 samples)
• NDC 00049-3160-44 — Voriconazole 40 mg/mL oral suspensionAI (252 hospitals, 26,044–26,998 samples)
• NDC 00409-4900-34 — Sodium bicarbonate 8.4% IV syringeAI (201 hospitals, 26,034–26,997 samples)
• NDC 61314-0014-25 — Diclofenac sodium 0.1% eye drops, 2.5 mL bottleAI (413 hospitals, 26,023–26,986 samples)
• NDC 60687-0161-01 — Haloperidol 5 mg tablets, blister pack of 100AI (489 hospitals, 26,344–26,983 samples)
• NDC 60432-0465-51 — Lidocaine 4% topical solutionAI (224 hospitals, 26,047–26,983 samples)
• NDC 00264-7510-00 — Dextrose 5% intravenous solutionAI (529 hospitals, 26,118–26,982 samples)
• NDC 00517-2102-25 — Potassium phosphate intravenous solutionAI (121 hospitals, 26,080–26,980 samples)
• NDC 70069-0746-01 — Potassium phosphate intravenous solutionAI (95 hospitals, 26,080–26,980 samples)
• NDC 51672-1301-02 — AMMONIUM LACTATE 12 % TOPICAL CREAMAI (31 hospitals, 26,080–26,980 samples)
• NDC 00386-0008-02 — Topical skin-numbing spray (norflurane and pentafluoropropane)AI (215 hospitals, 26,142–26,979 samples)
• NDC 00386-0001-02 — Ethyl chloride topical sprayAI (216 hospitals, 26,163–26,973 samples)
• NDC 60687-0669-01 — Methimazole 5 mg tabletsAI (461 hospitals, 26,342–26,963 samples)
• NDC 00054-0244-24 — codeine sulfate 30 mg tabletAI (478 hospitals, 26,405–26,963 samples)
• NDC 00641-6146-25 — Dexamethasone sodium phosphate 4 mg/mL injectionAI (179 hospitals, 25,089–26,961 samples)
• NDC 42852-0401-10 — Midazolam in sodium chloride IV solutionAI (17 hospitals, 26,613–26,955 samples)
• NDC 61553-0270-52 — Midazolam in sodium chloride IV solutionAI (33 hospitals, 26,613–26,955 samples)
• NDC 72888-0083-01 — ISOSORBIDE DINITRATE 20 MG TABLETAI (151 hospitals, 26,360–26,954 samples)
• NDC 00338-1147-03 — Amino acid, dextrose and electrolyte IV solutionAI (278 hospitals, 26,716–26,950 samples)
• NDC 58980-0780-21 — Balsam Peru and castor oil ointmentAI (403 hospitals, 26,019–26,946 samples)
• NDC 17478-0224-12 — PILOCARPINE 2 % EYE DROPSAI (138 hospitals, 26,138–26,939 samples)
• NDC 00591-2070-72 — Lidocaine and prilocaine numbing creamAI (132 hospitals, 26,138–26,939 samples)
• NDC 17478-0097-12 — CYCLOPENTOLATE 2 % EYE DROPSAI (61 hospitals, 26,138–26,939 samples)
• NDC 71506-0019-59 — Vancomycin 2 gram IV bag in sodium chlorideAI (154 hospitals, 25,750–26,938 samples)
• NDC 46287-0006-04 — Sodium polystyrene sulfonate sorbitol enemaAI (251 hospitals, 26,018–26,936 samples)
• NDC 00409-6653-05 — Potassium chloride IV solutionAI (654 hospitals, 25,370–26,936 samples)
• NDC 00409-2267-54 — Labetalol 5 mg/mL intravenous syringeAI (314 hospitals, 25,764–26,934 samples)
• NDC 59762-0055-01 — Medroxyprogesterone acetate 2.5 mg tabletsAI (331 hospitals, 26,358–26,934 samples)
• NDC 68084-0859-01 — Levetiracetam 250 mg oral tabletsAI (469 hospitals, 26,338–26,923 samples)
• NDC 00904-6988-61 — Dicyclomine 20 mg tabletsAI (352 hospitals, 26,308–26,920 samples)
• NDC 72888-0052-01 — Metolazone 2.5 mg oral tabletsAI (310 hospitals, 26,337–26,913 samples)
• NDC 50268-0535-15 — Metronidazole 500 mg tabletsAI (314 hospitals, 26,337–26,913 samples)
• NDC 00832-1217-01 — Warfarin sodium 6 mg oral tabletsAI (222 hospitals, 26,337–26,913 samples)
• NDC 00409-3977-03 — Bacteriostatic water for injectionAI (490 hospitals, 26,353–26,911 samples)
• NDC 16571-0661-01 — Meclizine 25 mg oral tabletAI (177 hospitals, 26,336–26,903 samples)
• NDC 51672-4047-09 — Carbamazepine oral suspension 100 mg per 5 mL, 450 mL bottleAI (562 hospitals, 26,336–26,903 samples)
• NDC 00904-6008-60 — LORazepam 1 mg tabletAI (198 hospitals, 26,336–26,903 samples)
• NDC 67877-0222-05 — gabapentin 100 mg capsuleAI (186 hospitals, 26,335–26,893 samples)
• NDC 60687-0627-01 — Lorazepam 0.5 mg oral tabletsAI (237 hospitals, 26,335–26,893 samples)
• NDC 00904-7417-61 — Methadone hydrochloride 10 mg tabletAI (269 hospitals, 26,334–26,883 samples)
• NDC 25021-0684-05 — Ketamine 100 mg/mL injectionAI (95 hospitals, 26,070–26,880 samples)
• NDC 70710-1876-01 — Zinc sulfate intravenous solutionAI (53 hospitals, 26,070–26,880 samples)
• NDC 72603-0305-01 — Lacosamide oral solution, 10 mg/mLAI (138 hospitals, 26,070–26,880 samples)
• NDC 00904-7340-12 — Hydrocortisone rectal suppositoryAI (54 hospitals, 26,070–26,880 samples)
• NDC 72603-0530-01 — PHENYLEPHRINE 10 % EYE DROPSAI (61 hospitals, 26,070–26,880 samples)
• NDC 61314-0665-05 — Apraclonidine 0.5% eye drops, 5 mL bottleAI (462 hospitals, 25,916–26,879 samples)